Prostate Artery Embolisation maintains it effectiveness for at least three years after patients undergo the therapy, according to research presented at the Society of Interventional Radiology's 2017 annual scientific meeting. The study was awarded as the "Abstract of the Year".
This study of 1000 men is the largest of its kind to evaluate the long term effectiveness of prostate artery embolisation.
Researchers also found that embolisation is especially effective in men with benign prostatic hyperplasia who also have acute urinary retention or the inability to voluntarily urinate and in patients with very large prostates who are normally treated with open surgery.
"Prostate artery embolisation gives men with benign prostatic hyperplasia a treatment option that is less invasive than other therapies and allows them to return to their normal lives sooner," said Joao Martins Pisco, an interventional radiologist in Portugal and the lead author. "Time and time again, I see patients who are relieved to find out about prostate artery embolisation because they are not able to tolerate medications for benign prostatic hyperplasia due to their side effects. These men also do not want traditional surgery because it involves greater risks, has possible sexual side effects, and has a recovery time that is relatively long compared to prostate artery embolisation."
"Our results demonstrate that this minimally invasive treatment is successful in the long term and should always be presented to patients who are exploring options to resolve their benign prostatic hyperplasia" remaked Pisco
To read the full article click here or to discuss Prostate Artery Embolisation with Dr Stuart Lyon please call our rooms on 8060 4279.